University of Adelaide research into health and fertility has been funded in the latest round of the National Health and ...

CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell.

CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. Another industry also offers innovation and ...

Nurix Therapeutics, Inc. stock slid 40% after promising NX-5948 results in CLL. NX-5948 shows efficacy in heavily pre-treated CLL patients, click for more on NRIX.

Chimera Investment Corporation is a specialty finance company that invests, either directly or indirectly through its subsidiaries, in residential mortgage-backed securities (RMBS), residential ...

Their CRISPR-Cas-mediated mutagenesis in vivo shows that mutation of the two RTKs causes acceleration of pupation, which is consistent with the mutant phenotype of the intracellular JH receptor, Met1.